Company Profiles

driven by the PitchBook Platform

Alcyone Lifesciences

Description

Developer of medical devices to treat diseases of the brain. The company is focused on development of novel treatment modalities for difficult neurological conditions. It has developed a platform for delivery of therapy to the brain, as well as a novel technology to manage cerebrospinal fluid (CSF) shunt occlusions.

2010

Founded

PRIVATE

Status

11-50

Employees

Early Stage VC

Latest Deal Type

$3.64M

Latest Deal Amount

$10.5M

Total Amount Raised

Description

Developer of medical devices to treat diseases of the brain. The company is focused on development of novel treatment modalities for difficult neurological conditions. It has developed a platform for delivery of therapy to the brain, as well as a novel technology to manage cerebrospinal fluid (CSF) shunt occlusions.

Website:

www.alcyonels.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Therapeutic Devices

Other Industries

Drug Delivery

Primary Office

250 Jackson Street Unit 494 Mill Number 5 Building Lowell, MA 01852United States +1 (978) 709-1946
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Alcyone Lifesciences's full profile, request a free trial.

Alcyone Lifesciences Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Alcyone Lifesciences Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Alcyone Lifesciences Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Edgar D. Jannotta, Jr.Angel (individual)000 0000000 0000
Harbor Light Capital PartnersVenture CapitalMinority000 0000000 0000
Individual InvestorAngel (individual)Minority000 0000000 0000
Edgar D. Jannotta, Jr. Angel (individual)
Harbor Light Capital Partners Venture Capital
Individual Investor Angel (individual)

Alcyone Lifesciences Executive Team (5)

NameTitleBoard
Seat
Contact
Info
PJ AnandCo-Founder, Board Member and Chief Executive Officer
Deep SinghDirector of Product Development
Adam Fleisher MDCo-Founder
Elsa AbruzzoVice President of Regulatory, Quality and Clinical Affairs
Todd TombaVice President, Product Development
PJ Anand Co-Founder, Board Member and Chief Executive Officer
Deep Singh Director of Product Development
Adam Fleisher MD Co-Founder
Elsa Abruzzo Vice President of Regulatory, Quality and Clinical Affairs
Todd Tomba Vice President, Product Development

Alcyone Lifesciences Board Members (4)

NameRepresentingRoleSinceContact
Info
Cameron Durrant MDSelfBoard Member000 0000
David Donabedian Ph.DSelfBoard Member000 0000
Edgar Jannotta Jr.Edgar JannottaAngel (individual)000 0000
Richard UptonHarbor Light Capital PartnersGeneral Partner000 0000
Cameron Durrant MD Board Member Self
David Donabedian Ph.D Board Member Self
Edgar Jannotta Jr. Angel (individual) Edgar Jannotta
Richard Upton General Partner Harbor Light Capital Partners
Request full access to PitchBook